Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:208-213

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gylling, H.
Right arrow Articles by Miettinen, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gylling, H.
Right arrow Articles by Miettinen, T. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
*Genetics Home Reference
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:208-213.)
© 1995 American Heart Association, Inc.


Articles

Cholesterol Absorption and Metabolism and LDL Kinetics in Healthy Men With Different Apoprotein E Phenotypes and Apoprotein B Xba I and LDL Receptor Pvu II Genotypes

Helena Gylling; Kimmo Kontula; Tatu A. Miettinen

From the Second Department of Medicine, University of Helsinki, Finland.

Correspondence to Tatu A. Miettinen, MD, Second Department of Medicine, University of Helsinki, Haartmaninkatu 4, FIN-00290 Helsinki, Finland.

Abstract Apoprotein (apo) E, apoB Xba I, and LDL receptor gene Pvu II polymorphisms are associated with LDL cholesterol level, but little is known about cholesterol and LDL metabolism in subjects with the latter two genetic polymorphisms alone or in combination with different apoE phenotypes. We studied cholesterol absorption efficiency, cholesterol and bile acid synthesis, and LDL apoB kinetics in 52 healthy men and related the metabolic results to the apoB Xba I and LDL receptor Pvu II restriction fragment length polymorphism (RFLP) and apoE phenotypes. New findings were as follows. ApoB Xba I polymorphism was not associated with the metabolic variables of cholesterol, but LDL receptor Pvu II RFLP was associated with fractional catabolic rate for LDL apoB, cholesterol absorption, and cholesterol and bile acid synthesis. ApoE polymorphism exerted the most powerful effect on the LDL cholesterol concentration, so that the apoE2 subjects had the lowest LDL cholesterol and apoB levels and cholesterol absorption, and the highest fractional catabolic rate and bile acid and cholesterol synthesis compared with the apoE3 or especially apoE4 phenotypes in different genetic combinations. In multiple stepwise regression analysis with LDL cholesterol as the dependent and the genetic and metabolic parameters as the independent variables, 47.0% (n=35, P<.001) of the variability of LDL cholesterol was explained by the apoE polymorphism, 7.1% (P<.05) by the LDL receptor Pvu II RFLP, and 11.3% (P<.01) by bile acid synthesis, while the contribution of the apoB Xba I RFLP was nonsignificant. In conclusion, LDL cholesterol level was lowest in subjects with the {epsilon}2 allele, irrespective of their Xba I or Pvu II genotypes; this was due to lower cholesterol absorption efficiency, more effective cholesterol and bile acid synthesis, and more efficient fractional catabolic rate in carriers of the {epsilon}2 allele when compared with the other genetic subgroups.


Key Words: apoprotein B • apoprotein E • cholesterol absorption • cholesterol synthesis • LDL kinetics




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Altenburg, J. Arbones-Mainar, L. Johnson, J. Wilder, and N. Maeda
Human LDL Receptor Enhances Sequestration of ApoE4 and VLDL Remnants on the Surface of Hepatocytes but Not Their Internalization in Mice
Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1104 - 1110.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D.C. Chan, G.F. Watts, P.H.R. Barrett, A.J. Whitfield, and F.M. van Bockxmeer
ATP-Binding Cassette Transporter G8 Gene As a Determinant of Apolipoprotein B-100 Kinetics in Overweight Men
Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 2188 - 2191.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. Moreno, F. Perez-Jimenez, C. Marin, P. Gomez, P. Perez-Martinez, R. Moreno, C. Bellido, F. Fuentes, and J. Lopez-Miranda
The Effect of Dietary Fat on LDL Size Is Influenced by Apolipoprotein E Genotype in Healthy Subjects
J. Nutr., October 1, 2004; 134(10): 2517 - 2522.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. M. Lottenberg, V. S. Nunes, E. R. Nakandakare, M. Neves, M. Bernik, L. Lagrost, J. E. dos Santos, and E. Quintao
The Human Cholesteryl Ester Transfer Protein I405V Polymorphism Is Associated with Plasma Cholesterol Concentration and Its Reduction by Dietary Phytosterol Esters
J. Nutr., June 1, 2003; 133(6): 1800 - 1805.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. von Bergmann, D. Lutjohann, B. Lindenthal, and A. Steinmetz
Efficiency of intestinal cholesterol absorption in humans is not related to apoE phenotype
J. Lipid Res., January 1, 2003; 44(1): 193 - 197.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Gylling, K. Kontula, U.-M. Koivisto, H. E. Miettinen, and T. A. Miettinen
Polymorphisms of the Genes Encoding Apoproteins A-I, B, C-III, and E and LDL Receptor, and Cholesterol and LDL Metabolism During Increased Cholesterol Intake: Common Alleles of the Apoprotein E Gene Show the Greatest Regulatory Impact
Arterioscler Thromb Vasc Biol, January 1, 1997; 17(1): 38 - 44.
[Abstract] [Full Text]